Trial Profile
Inhaled Iloprost for patients with pulmonary arterial hypertension and right heart failure:a pilot feasibility trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Apr 2013
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Heart failure; Pulmonary hypertension
- Focus Adverse reactions; Therapeutic Use
- 25 Aug 2011 New trial record